ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 44

Physical Function, Hyperuricemia and Gout in Older Adults

Mara McAdams-DeMarco1, Bridget Burke2, Andrew Law3, Anna Kottgen4, Alan N. Baer5 and Josef Coresh1, 1Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD, 3Epidemiology, Johns Hopkins, Baltimore, MD, 4Renal Division, University Hospital Freiburg, Freiburg, Germany, 5Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Aging, gout and physical function

  • Tweet
  • Email
  • Print
Session Information

Title: Epidemiology and Public Health: Osteoporosis, Non-Inflammatory Arthritis and More

Session Type: Abstract Submissions (ACR)

Background/Purpose: The prevalence of gout is higher in older adults than in younger adults and these patients are at risk of physical disability. We sought to determine the prevalence of and risk factors for impaired physical function in relation to gout status and hyperuricemia.

Methods: We studied gout, hyperuricemia, and function in 5,819 older adults (age>65) using the Atherosclerosis Risk in Communities cohort, a prospective US population-based cohort study of middle-aged adults enrolled between 1987-1989 with ongoing annual follow-up through 2012. Differences in lower (Short Physical Performance Battery (SPPB) and 4 meter walk test, measured in 2011-2013) and upper extremity function (grip strength) by gout status and by hyperuricemia prevalence were estimated: adjusted ordinal logistic regression for SPPB and modified Poisson regression for 4 meter walk test and grip strength. The risk of poor physical function (lowest quartile of grip strength, lowest quartile of SPPB and highest quartile of 4 meter walk test) was estimated using modified Poison regression. Characteristics of gout participants with poor physical function were identified using modified Poisson regression.

Results: There were 595 (10.2%; women: 7.1% and men: 14.6%) participants with gout and 1,242 (21.3%; women: 16.2% and men: 28.4%) with hyperuricemia. There was no difference in grip strength by history of gout (mean difference = -0.29, 95% CI: -0.90, 0.32; P=0.36) nor risk of poor grip strength by history of gout (RR=1.07, 95% CI: 0.95-1.21; P=0.27). Participants with gout had 0.70-times (95% CI: 0.60, 0.82; P<0.001) the odds of 1-unit increase in the SPPB score, such that those with gout had worse performance on the SPPB and participants with gout were 1.28-times (95% CI: 1.15-1.42; P<0.001) more likely to have poor SPPB performance. Participants with gout had slower 4 meter walk test by history of gout (mean difference = 0.23, 95% CI: 0.12, 0.33; P<0.001) and were at 1.24-fold (95% CI: 1.10-1.41; P=0.001) increased risk of poor 4 meter walk test performance. Results were similar when comparing grip strength, SPPB and 4 meter walk test by hyperuricemia (Table). Among participants with gout, older participants (for every 5 year increase in age, RR=1.42, 95% CI: 1.28, 1.59), black participants (RR=1.58, 95% CI: 1.25, 2.00), participants with higher BMI (for every 5 kg/m2 increase in BMI, RR=1.18, 95% CI: 1.07, 1.29), and participants who were current smokers (RR=1.65, 95% CI: 1.14, 2.38) were at highest risk of poor 4 meter walk time; similar results were observed for poor SPPB score.

Conclusion: Older adults with gout and hyperuricemia are more likely to have poor lower but not upper body function. Additionally, we identified a group of gout participants with high risk of poor lower extremity function, namely, older age, men, with higher BMIs, and current smokers.


Disclosure:

M. McAdams-DeMarco,
None;

B. Burke,
None;

A. Law,
None;

A. Kottgen,
None;

A. N. Baer,
None;

J. Coresh,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/physical-function-hyperuricemia-and-gout-in-older-adults/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology